246 related articles for article (PubMed ID: 35040083)
21. Anti-Ro52/TRIM21 serological subsets identify differential clinical and laboratory parameters.
Lee AYS; Lin MW; Reed JH
Clin Rheumatol; 2022 Nov; 41(11):3495-3501. PubMed ID: 35871174
[TBL] [Abstract][Full Text] [Related]
22. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
[TBL] [Abstract][Full Text] [Related]
23. Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome.
Burbelo PD; Leahy HP; Issa AT; Groot S; Baraniuk JN; Nikolov NP; Illei GG; Iadarola MJ
Autoimmunity; 2009 Sep; 42(6):515-24. PubMed ID: 19657778
[TBL] [Abstract][Full Text] [Related]
24. Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis.
Nayebirad S; Mohamadi A; Yousefi-Koma H; Javadi M; Farahmand K; Atef-Yekta R; Tamartash Z; Jameie M; Mohammadzadegan AM; Kavosi H
BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 38030264
[TBL] [Abstract][Full Text] [Related]
25. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection.
Menéndez A; Gómez J; Escanlar E; Caminal-Montero L; Mozo L
Autoimmunity; 2013 Feb; 46(1):32-9. PubMed ID: 23039326
[TBL] [Abstract][Full Text] [Related]
26. The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.
Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
Clin Exp Immunol; 2018 Dec; 194(3):315-326. PubMed ID: 30178506
[TBL] [Abstract][Full Text] [Related]
27. The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren's syndrome, cancers, and cancer metabolism.
Hsu CH; Yu YL
Cancer Cell Int; 2023 Nov; 23(1):289. PubMed ID: 37993883
[TBL] [Abstract][Full Text] [Related]
28. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.
Ohlsson M; Jonsson R; Brokstad KA
Scand J Immunol; 2002 Nov; 56(5):456-69. PubMed ID: 12410795
[TBL] [Abstract][Full Text] [Related]
29. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
[TBL] [Abstract][Full Text] [Related]
30. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of anti-Ro52 detection in systemic autoimmunity.
Dugar M; Cox S; Limaye V; Gordon TP; Roberts-Thomson PJ
Postgrad Med J; 2010 Feb; 86(1012):79-82. PubMed ID: 20145055
[TBL] [Abstract][Full Text] [Related]
32. TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease.
Jones EL; Laidlaw SM; Dustin LB
Front Immunol; 2021; 12():738473. PubMed ID: 34552597
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sjögren's syndrome and systemic sclerosis.
Andraos R; Ahmad A; Eriksson P; Dahlström Ö; Wirestam L; Dahle C; Hesselstrand R; Bengtsson AA; Jönsen A; Andréasson K; Sjöwall C
Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36581379
[TBL] [Abstract][Full Text] [Related]
34. Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies.
Arase N; Tsuji H; Takamatsu H; Jin H; Konaka H; Hamaguchi Y; Tonomura K; Kotobuki Y; Ueda-Hayakawa I; Matsuoka S; Hirano T; Yorifuji H; Murota H; Ohmura K; Nakashima R; Sato T; Kumanogoh A; Katayama I; Arase H; Fujimoto M
J Autoimmun; 2022 Jan; 126():102774. PubMed ID: 34896887
[TBL] [Abstract][Full Text] [Related]
35. Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody.
Sclafani A; D'Silva KM; Little BP; Miloslavsky EM; Locascio JJ; Sharma A; Montesi SB
Respir Res; 2019 Nov; 20(1):256. PubMed ID: 31718649
[TBL] [Abstract][Full Text] [Related]
36. Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.
Espinosa A; Hennig J; Ambrosi A; Anandapadmanaban M; Abelius MS; Sheng Y; Nyberg F; Arrowsmith CH; Sunnerhagen M; Wahren-Herlenius M
J Biol Chem; 2011 Oct; 286(42):36478-91. PubMed ID: 21862588
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.
Kyriakidis NC; Kapsogeorgou EK; Gourzi VC; Konsta OD; Baltatzis GE; Tzioufas AG
Clin Exp Immunol; 2014 Dec; 178(3):548-60. PubMed ID: 25098814
[TBL] [Abstract][Full Text] [Related]
38. Rapid serological detection of autoantibodies associated with Sjögren's syndrome.
Burbelo PD; Ching KH; Issa AT; Loftus CM; Li Y; Satoh M; Reeves WH; Iadarola MJ
J Transl Med; 2009 Sep; 7():83. PubMed ID: 19778440
[TBL] [Abstract][Full Text] [Related]
39. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
40. Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases.
Clarke T; Du P; Kumar S; Okitsu SL; Schuette M; An Q; Zhang J; Tzvetkov E; Jensen MA; Niewold TB; Ferre EMN; Nardone J; Lionakis MS; Vlach J; DeMartino J; Bender AT
Front Immunol; 2023; 14():1106537. PubMed ID: 36845162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
